Identification of PB2 Mutations Responsible for the Efficient Replication of H5N1 Influenza Viruses in Human Lung Epithelial Cells
Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60% mortality. However, efficient transmission of H5N1 viruses among humans has yet to occur, suggesting that further adaptation of H5N1 viruses...
Saved in:
Published in | Journal of virology Vol. 89; no. 7; pp. 3947 - 3956 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
01.04.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60% mortality. However, efficient transmission of H5N1 viruses among humans has yet to occur, suggesting that further adaptation of H5N1 viruses to humans is required for their efficient transmission among humans. The viral determinants for efficient replication in humans are currently poorly understood. Here, we report that the polymerase PB2 protein of an H5N1 influenza virus isolated from a human in Vietnam (A/Vietnam/UT36285/2010, virus 36285) increased the growth ability of an avian H5N1 virus (A/wild bird/Anhui/82/2005, virus Wb/AH82) in human lung epithelial A549 cells (however, the reassortant virus did not replicate more efficiently than human 36285 virus). Furthermore, we demonstrate that the amino acid residues at positions 249, 309, and 339 of the PB2 protein from this human isolate were responsible for its efficient replication in A549 cells. PB2 residues 249G and 339M, which are found in the human H5N1 virus, are rare in H5N1 viruses from both human and avian sources. Interestingly, PB2-249G is found in over 30% of human seasonal H3N2 viruses, which suggests that H5N1 viruses may replicate well in human cells when they acquire this mutation. Our data are of value to H5N1 virus surveillance.
IMPORTANCE
Highly pathogenic H5N1 avian influenza viruses must acquire mutations to overcome the species barrier between avian species and humans. When H5N1 viruses replicate in human respiratory cells, they can acquire amino acid mutations that allow them to adapt to humans through continuous selective pressure. Several amino acid mutations have been shown to be advantageous for virus adaptation to mammalian hosts. Here, we found that amino acid changes at positions 249, 309, and 339 of PB2 contribute to efficient replication of avian H5N1 viruses in human lung cells. These findings are beneficial for evaluating the pandemic risk of circulating avian viruses and for further functional analysis of PB2. |
---|---|
AbstractList | Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60% mortality. However, efficient transmission of H5N1 viruses among humans has yet to occur, suggesting that further adaptation of H5N1 viruses to humans is required for their efficient transmission among humans. The viral determinants for efficient replication in humans are currently poorly understood. Here, we report that the polymerase PB2 protein of an H5N1 influenza virus isolated from a human in Vietnam (A/Vietnam/UT36285/2010, virus 36285) increased the growth ability of an avian H5N1 virus (A/wild bird/Anhui/82/2005, virus Wb/AH82) in human lung epithelial A549 cells (however, the reassortant virus did not replicate more efficiently than human 36285 virus). Furthermore, we demonstrate that the amino acid residues at positions 249, 309, and 339 of the PB2 protein from this human isolate were responsible for its efficient replication in A549 cells. PB2 residues 249G and 339M, which are found in the human H5N1 virus, are rare in H5N1 viruses from both human and avian sources. Interestingly, PB2-249G is found in over 30% of human seasonal H3N2 viruses, which suggests that H5N1 viruses may replicate well in human cells when they acquire this mutation. Our data are of value to H5N1 virus surveillance.UNLABELLEDHighly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60% mortality. However, efficient transmission of H5N1 viruses among humans has yet to occur, suggesting that further adaptation of H5N1 viruses to humans is required for their efficient transmission among humans. The viral determinants for efficient replication in humans are currently poorly understood. Here, we report that the polymerase PB2 protein of an H5N1 influenza virus isolated from a human in Vietnam (A/Vietnam/UT36285/2010, virus 36285) increased the growth ability of an avian H5N1 virus (A/wild bird/Anhui/82/2005, virus Wb/AH82) in human lung epithelial A549 cells (however, the reassortant virus did not replicate more efficiently than human 36285 virus). Furthermore, we demonstrate that the amino acid residues at positions 249, 309, and 339 of the PB2 protein from this human isolate were responsible for its efficient replication in A549 cells. PB2 residues 249G and 339M, which are found in the human H5N1 virus, are rare in H5N1 viruses from both human and avian sources. Interestingly, PB2-249G is found in over 30% of human seasonal H3N2 viruses, which suggests that H5N1 viruses may replicate well in human cells when they acquire this mutation. Our data are of value to H5N1 virus surveillance.Highly pathogenic H5N1 avian influenza viruses must acquire mutations to overcome the species barrier between avian species and humans. When H5N1 viruses replicate in human respiratory cells, they can acquire amino acid mutations that allow them to adapt to humans through continuous selective pressure. Several amino acid mutations have been shown to be advantageous for virus adaptation to mammalian hosts. Here, we found that amino acid changes at positions 249, 309, and 339 of PB2 contribute to efficient replication of avian H5N1 viruses in human lung cells. These findings are beneficial for evaluating the pandemic risk of circulating avian viruses and for further functional analysis of PB2.IMPORTANCEHighly pathogenic H5N1 avian influenza viruses must acquire mutations to overcome the species barrier between avian species and humans. When H5N1 viruses replicate in human respiratory cells, they can acquire amino acid mutations that allow them to adapt to humans through continuous selective pressure. Several amino acid mutations have been shown to be advantageous for virus adaptation to mammalian hosts. Here, we found that amino acid changes at positions 249, 309, and 339 of PB2 contribute to efficient replication of avian H5N1 viruses in human lung cells. These findings are beneficial for evaluating the pandemic risk of circulating avian viruses and for further functional analysis of PB2. Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60% mortality. However, efficient transmission of H5N1 viruses among humans has yet to occur, suggesting that further adaptation of H5N1 viruses to humans is required for their efficient transmission among humans. The viral determinants for efficient replication in humans are currently poorly understood. Here, we report that the polymerase PB2 protein of an H5N1 influenza virus isolated from a human in Vietnam (A/Vietnam/UT36285/2010, virus 36285) increased the growth ability of an avian H5N1 virus (A/wild bird/Anhui/82/2005, virus Wb/AH82) in human lung epithelial A549 cells (however, the reassortant virus did not replicate more efficiently than human 36285 virus). Furthermore, we demonstrate that the amino acid residues at positions 249, 309, and 339 of the PB2 protein from this human isolate were responsible for its efficient replication in A549 cells. PB2 residues 249G and 339M, which are found in the human H5N1 virus, are rare in H5N1 viruses from both human and avian sources. Interestingly, PB2-249G is found in over 30% of human seasonal H3N2 viruses, which suggests that H5N1 viruses may replicate well in human cells when they acquire this mutation. Our data are of value to H5N1 virus surveillance. IMPORTANCE Highly pathogenic H5N1 avian influenza viruses must acquire mutations to overcome the species barrier between avian species and humans. When H5N1 viruses replicate in human respiratory cells, they can acquire amino acid mutations that allow them to adapt to humans through continuous selective pressure. Several amino acid mutations have been shown to be advantageous for virus adaptation to mammalian hosts. Here, we found that amino acid changes at positions 249, 309, and 339 of PB2 contribute to efficient replication of avian H5N1 viruses in human lung cells. These findings are beneficial for evaluating the pandemic risk of circulating avian viruses and for further functional analysis of PB2. Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60% mortality. However, efficient transmission of H5N1 viruses among humans has yet to occur, suggesting that further adaptation of H5N1 viruses to humans is required for their efficient transmission among humans. The viral determinants for efficient replication in humans are currently poorly understood. Here, we report that the polymerase PB2 protein of an H5N1 influenza virus isolated from a human in Vietnam (A/Vietnam/UT36285/2010, virus 36285) increased the growth ability of an avian H5N1 virus (A/wild bird/Anhui/82/2005, virus Wb/AH82) in human lung epithelial A549 cells (however, the reassortant virus did not replicate more efficiently than human 36285 virus). Furthermore, we demonstrate that the amino acid residues at positions 249, 309, and 339 of the PB2 protein from this human isolate were responsible for its efficient replication in A549 cells. PB2 residues 249G and 339M, which are found in the human H5N1 virus, are rare in H5N1 viruses from both human and avian sources. Interestingly, PB2-249G is found in over 30% of human seasonal H3N2 viruses, which suggests that H5N1 viruses may replicate well in human cells when they acquire this mutation. Our data are of value to H5N1 virus surveillance. IMPORTANCE Highly pathogenic H5N1 avian influenza viruses must acquire mutations to overcome the species barrier between avian species and humans. When H5N1 viruses replicate in human respiratory cells, they can acquire amino acid mutations that allow them to adapt to humans through continuous selective pressure. Several amino acid mutations have been shown to be advantageous for virus adaptation to mammalian hosts. Here, we found that amino acid changes at positions 249, 309, and 339 of PB2 contribute to efficient replication of avian H5N1 viruses in human lung cells. These findings are beneficial for evaluating the pandemic risk of circulating avian viruses and for further functional analysis of PB2. Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60% mortality. However, efficient transmission of H5N1 viruses among humans has yet to occur, suggesting that further adaptation of H5N1 viruses to humans is required for their efficient transmission among humans. The viral determinants for efficient replication in humans are currently poorly understood. Here, we report that the polymerase PB2 protein of an H5N1 influenza virus isolated from a human in Vietnam (A/Vietnam/UT36285/2010, virus 36285) increased the growth ability of an avian H5N1 virus (A/wild bird/Anhui/82/2005, virus Wb/AH82) in human lung epithelial A549 cells (however, the reassortant virus did not replicate more efficiently than human 36285 virus). Furthermore, we demonstrate that the amino acid residues at positions 249, 309, and 339 of the PB2 protein from this human isolate were responsible for its efficient replication in A549 cells. PB2 residues 249G and 339M, which are found in the human H5N1 virus, are rare in H5N1 viruses from both human and avian sources. Interestingly, PB2-249G is found in over 30% of human seasonal H3N2 viruses, which suggests that H5N1 viruses may replicate well in human cells when they acquire this mutation. Our data are of value to H5N1 virus surveillance. Highly pathogenic H5N1 avian influenza viruses must acquire mutations to overcome the species barrier between avian species and humans. When H5N1 viruses replicate in human respiratory cells, they can acquire amino acid mutations that allow them to adapt to humans through continuous selective pressure. Several amino acid mutations have been shown to be advantageous for virus adaptation to mammalian hosts. Here, we found that amino acid changes at positions 249, 309, and 339 of PB2 contribute to efficient replication of avian H5N1 viruses in human lung cells. These findings are beneficial for evaluating the pandemic risk of circulating avian viruses and for further functional analysis of PB2. |
Author | Le, Mai Q. Nidom, Chairul A. Kawaoka, Yoshihiro Sakai-Tagawa, Yuko Yamaji, Reina Qurnianingsih, Ema Chen, Hualan Ito, Mutsumi Yamada, Shinya Li, Chengjun |
Author_xml | – sequence: 1 givenname: Reina surname: Yamaji fullname: Yamaji, Reina organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan – sequence: 2 givenname: Shinya surname: Yamada fullname: Yamada, Shinya organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan – sequence: 3 givenname: Mai Q. surname: Le fullname: Le, Mai Q. organization: National Institute of Hygiene and Epidemiology, Hanoi, Vietnam – sequence: 4 givenname: Chengjun surname: Li fullname: Li, Chengjun organization: State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China – sequence: 5 givenname: Hualan surname: Chen fullname: Chen, Hualan organization: State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China – sequence: 6 givenname: Ema surname: Qurnianingsih fullname: Qurnianingsih, Ema organization: Avian Influenza Research Center, Airlangga University, Surabaya, Indonesia – sequence: 7 givenname: Chairul A. surname: Nidom fullname: Nidom, Chairul A. organization: Avian Influenza Research Center, Airlangga University, Surabaya, Indonesia – sequence: 8 givenname: Mutsumi surname: Ito fullname: Ito, Mutsumi organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan – sequence: 9 givenname: Yuko surname: Sakai-Tagawa fullname: Sakai-Tagawa, Yuko organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan – sequence: 10 givenname: Yoshihiro surname: Kawaoka fullname: Kawaoka, Yoshihiro organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Wisconsin, USA, Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25609813$$D View this record in MEDLINE/PubMed |
BookMark | eNqNks1v1DAQxS1URLeFG2fkIwdSPP5I7AsSXS3souVDCCpuluPYrZHXCXGC1B75yzHdFhXEgdPImt97euOZI3SQ-uQQegzkBIDK52_ONieEMSor4PfQAoiSlRDAD9CCEEorweSXQ3SU81dCgPOaP0CHVNQFA7ZAPzadS1PwwZop9An3Hn84pfjtPF2_M_7o8lBqaKPDvh_xdOHwyhc-FF3pDvGOdC3eAd4kH2eXrgw-C-OcXcYh4fW8Mwlv53SOV0MoJjGYiJcuxvwQ3fcmZvfoph6jz69Wn5bravv-9Wb5cltZLtlUuZp2QhAQkihHvGiUEg2pbWMUSCNV7Rva8g6ctDUAF7ZlwvhWgeg4p6DYMXqx9x3mduc6W_KPJuphDDszXureBP1nJ4ULfd5_15yX_1W0GDy9MRj7b7PLk96FbMsIJrl-zhrqpmaCgmT_gda0sILIgj65G-t3ntsdFYDuATv2OY_Oaxv22ykpQ9RA9K9D0OUQ9PUhaOBF9Owv0a3vP_GfXR6z0w |
CitedBy_id | crossref_primary_10_1038_srep24154 crossref_primary_10_3390_v14112454 crossref_primary_10_3390_v16030357 crossref_primary_10_1128_JVI_01722_20 crossref_primary_10_1007_s00705_016_3137_8 crossref_primary_10_1038_s41426_018_0072_7 crossref_primary_10_1128_JVI_01930_19 crossref_primary_10_1080_13102818_2018_1541760 crossref_primary_10_1055_s_0044_1788039 crossref_primary_10_1111_tbed_13294 crossref_primary_10_1371_journal_pone_0226108 crossref_primary_10_3390_pathogens12010036 crossref_primary_10_1038_s41594_023_01043_2 crossref_primary_10_3390_vaccines9010026 crossref_primary_10_1007_s00705_016_2826_7 crossref_primary_10_3390_vaccines11111628 crossref_primary_10_1186_s12864_019_5820_0 crossref_primary_10_1016_j_virol_2015_03_009 crossref_primary_10_1038_s41541_021_00395_4 crossref_primary_10_1016_j_onehlt_2015_03_001 crossref_primary_10_3390_ijms25158550 crossref_primary_10_1038_s41426_018_0050_0 crossref_primary_10_1038_srep43691 crossref_primary_10_3390_v13122357 crossref_primary_10_1111_tbed_13601 crossref_primary_10_3389_fmicb_2019_01271 crossref_primary_10_1371_journal_pone_0312134 crossref_primary_10_3390_v14030643 |
Cites_doi | 10.1099/vir.0.018143-0 10.1038/nature07720 10.1038/nature07745 10.1371/journal.ppat.1000252 10.1038/ncomms6021 10.1093/oxfordjournals.aje.a118408 10.1371/journal.pone.0001190 10.1074/jbc.M111.262048 10.1128/JVI.06203-11 10.1056/NEJMra052211 10.1371/journal.ppat.0030133 10.1038/440435a 10.1099/vir.0.036434-0 10.1056/NEJMoa044021 10.1073/pnas.96.16.9345 10.1046/j.1365-2443.1999.00275.x 10.1128/AAC.38.12.2827 10.1006/viro.1994.1615 10.1056/NEJMra0707279 10.1126/science.279.5349.393 10.1016/0042-6822(83)90150-2 10.1371/journal.ppat.1003279 10.1128/JVI.79.18.12058-12064.2005 10.1128/JVI.00760-13 10.1038/nature03974 10.1371/journal.ppat.1001034 10.1371/journal.pone.0021740 10.1038/nature14008 10.1186/1471-2105-9-S1-S18 10.1038/nsmb.1421 10.1074/jbc.M112.392878 10.1006/viro.1999.9820 10.1128/JVI.01698-07 10.1186/1743-422X-10-243 10.1128/JVI.01694-10 10.1128/JVI.00980-13 10.1016/S0140-6736(08)60493-6 10.1371/journal.pone.0009025 10.1128/JVI.01373-09 10.1099/vir.0.80755-0 10.1126/science.1124513 10.1038/nsmb1212 10.1074/jbc.M300130200 10.1038/ncomms1804 10.1128/JVI.02677-05 10.1128/JVI.02642-09 |
ContentType | Journal Article |
Copyright | Copyright © 2015, American Society for Microbiology. All Rights Reserved. Copyright © 2015, American Society for Microbiology. All Rights Reserved. 2015 American Society for Microbiology |
Copyright_xml | – notice: Copyright © 2015, American Society for Microbiology. All Rights Reserved. – notice: Copyright © 2015, American Society for Microbiology. All Rights Reserved. 2015 American Society for Microbiology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T2 7U1 7U9 C1K H94 5PM |
DOI | 10.1128/JVI.03328-14 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Health and Safety Science Abstracts (Full archive) Risk Abstracts Virology and AIDS Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Risk Abstracts AIDS and Cancer Research Abstracts Health & Safety Science Abstracts Virology and AIDS Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | MEDLINE - Academic Risk Abstracts MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Adaptive Mutations of H5N1 Virus |
EISSN | 1098-5514 |
EndPage | 3956 |
ExternalDocumentID | PMC4403392 25609813 10_1128_JVI_03328_14 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | ISEW, Vietnam |
GeographicLocations_xml | – name: ISEW, Vietnam |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAFWJ AAGFI AAYJJ AAYXX ABPPZ ACGFO ACNCT ADBBV ADXHL AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CITATION CS3 D0S DIK E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A O9- OHT OK1 P2P RHI RNS RPM RSF TR2 UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM CGR CUY CVF ECM EIF NPM 7X8 7T2 7U1 7U9 C1K H94 5PM |
ID | FETCH-LOGICAL-c483t-e62d55015809e0f57995706c7a918a896f72b4d1e8c61145cb35afb915d442193 |
ISSN | 0022-538X 1098-5514 |
IngestDate | Thu Aug 21 14:00:26 EDT 2025 Sun Aug 24 04:13:21 EDT 2025 Thu Jul 10 19:14:24 EDT 2025 Mon Jul 21 06:02:08 EDT 2025 Tue Jul 01 01:02:36 EDT 2025 Thu Apr 24 23:06:34 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
License | Copyright © 2015, American Society for Microbiology. All Rights Reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c483t-e62d55015809e0f57995706c7a918a896f72b4d1e8c61145cb35afb915d442193 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Citation Yamaji R, Yamada S, Le MQ, Li C, Chen H, Qurnianingsih E, Nidom CA, Ito M, Sakai-Tagawa Y, Kawaoka Y. 2015. Identification of PB2 mutations responsible for the efficient replication of H5N1 influenza viruses in human lung epithelial cells. J Virol 89:3947–3956. doi:10.1128/JVI.03328-14. |
OpenAccessLink | https://jvi.asm.org/content/jvi/89/7/3947.full.pdf |
PMID | 25609813 |
PQID | 1662635508 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4403392 proquest_miscellaneous_1676352183 proquest_miscellaneous_1662635508 pubmed_primary_25609813 crossref_citationtrail_10_1128_JVI_03328_14 crossref_primary_10_1128_JVI_03328_14 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-04-01 |
PublicationDateYYYYMMDD | 2015-04-01 |
PublicationDate_xml | – month: 04 year: 2015 text: 2015-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | Journal of virology |
PublicationTitleAlternate | J Virol |
PublicationYear | 2015 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_48_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_41_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_46_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_35_2 Kurihara T (e_1_3_2_47_2) 2009; 35 19194458 - Nature. 2009 Apr 16;458(7240):909-13 18454157 - Nat Struct Mol Biol. 2008 May;15(5):500-6 18315849 - BMC Bioinformatics. 2008;9 Suppl 1:S18 20700447 - PLoS Pathog. 2010;6(8):e1001034 25409142 - Nature. 2014 Dec 18;516(7531):355-60 6868370 - Virology. 1983 Jun;127(2):361-73 22549831 - Nat Commun. 2012;3:802 9430591 - Science. 1998 Jan 16;279(5349):393-6 16192482 - N Engl J Med. 2005 Sep 29;353(13):1374-85 10430945 - Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50 21738783 - PLoS One. 2011;6(6):e21740 10484749 - Virology. 1999 Aug 15;261(1):15-9 25289523 - Nat Commun. 2014;5:5021 18199865 - N Engl J Med. 2008 Jan 17;358(3):261-73 20016035 - J Gen Virol. 2010 May;91(Pt 5):1284-9 22090209 - J Gen Virol. 2012 Mar;93(Pt 3):531-40 23616660 - J Virol. 2013 Jul;87(13):7200-9 17922570 - PLoS Pathog. 2007 Oct 5;3(10):1374-9 19793828 - J Virol. 2009 Dec;83(23):12325-35 10526235 - Genes Cells. 1999 Aug;4(8):475-85 18030326 - PLoS One. 2007;2(11):e1190 20140252 - PLoS One. 2010;5(2):e9025 20181719 - J Virol. 2010 May;84(9):4395-406 7975212 - Virology. 1994 Nov 15;205(1):17-23 12646557 - J Biol Chem. 2003 May 30;278(22):20381-8 16140781 - J Virol. 2005 Sep;79(18):12058-64 23886034 - Virol J. 2013;10:243 23436652 - J Biol Chem. 2013 Apr 19;288(16):11013-23 7695269 - Antimicrob Agents Chemother. 1994 Dec;38(12):2827-37 23555271 - PLoS Pathog. 2013 Mar;9(3):e1003279 15831934 - J Gen Virol. 2005 May;86(Pt 5):1239-49 16543414 - Science. 2006 Apr 21;312(5772):404-10 22090127 - J Virol. 2012 Feb;86(3):1750-7 16840327 - J Virol. 2006 Aug;80(15):7469-80 16554799 - Nature. 2006 Mar 23;440(7083):435-6 17310249 - Nat Struct Mol Biol. 2007 Mar;14(3):229-33 18400288 - Lancet. 2008 Apr 26;371(9622):1427-34 23926340 - J Virol. 2013 Oct;87(20):11063-75 19194459 - Nature. 2009 Apr 16;458(7240):914-8 20962098 - J Virol. 2011 Jan;85(1):357-65 19119420 - PLoS Pathog. 2009 Jan;5(1):e1000252 21816827 - J Biol Chem. 2011 Oct 7;286(40):34504-13 15668219 - N Engl J Med. 2005 Jan 27;352(4):333-40 18032512 - J Virol. 2008 Feb;82(3):1146-54 16007072 - Nature. 2005 Jul 14;436(7048):191-2 |
References_xml | – ident: e_1_3_2_20_2 doi: 10.1099/vir.0.018143-0 – ident: e_1_3_2_40_2 doi: 10.1038/nature07720 – ident: e_1_3_2_39_2 doi: 10.1038/nature07745 – ident: e_1_3_2_10_2 doi: 10.1371/journal.ppat.1000252 – ident: e_1_3_2_29_2 doi: 10.1038/ncomms6021 – ident: e_1_3_2_48_2 doi: 10.1093/oxfordjournals.aje.a118408 – ident: e_1_3_2_30_2 doi: 10.1371/journal.pone.0001190 – ident: e_1_3_2_9_2 doi: 10.1074/jbc.M111.262048 – ident: e_1_3_2_24_2 doi: 10.1128/JVI.06203-11 – ident: e_1_3_2_5_2 doi: 10.1056/NEJMra052211 – ident: e_1_3_2_11_2 doi: 10.1371/journal.ppat.0030133 – ident: e_1_3_2_19_2 doi: 10.1038/440435a – ident: e_1_3_2_22_2 doi: 10.1099/vir.0.036434-0 – ident: e_1_3_2_8_2 doi: 10.1056/NEJMoa044021 – ident: e_1_3_2_33_2 doi: 10.1073/pnas.96.16.9345 – ident: e_1_3_2_37_2 doi: 10.1046/j.1365-2443.1999.00275.x – ident: e_1_3_2_41_2 doi: 10.1128/AAC.38.12.2827 – ident: e_1_3_2_44_2 doi: 10.1006/viro.1994.1615 – ident: e_1_3_2_6_2 doi: 10.1056/NEJMra0707279 – ident: e_1_3_2_2_2 doi: 10.1126/science.279.5349.393 – ident: e_1_3_2_43_2 doi: 10.1016/0042-6822(83)90150-2 – ident: e_1_3_2_25_2 doi: 10.1371/journal.ppat.1003279 – ident: e_1_3_2_14_2 doi: 10.1128/JVI.79.18.12058-12064.2005 – ident: e_1_3_2_17_2 doi: 10.1128/JVI.00760-13 – ident: e_1_3_2_4_2 doi: 10.1038/nature03974 – ident: e_1_3_2_12_2 doi: 10.1371/journal.ppat.1001034 – ident: e_1_3_2_26_2 doi: 10.1371/journal.pone.0021740 – ident: e_1_3_2_34_2 doi: 10.1038/nature14008 – ident: e_1_3_2_31_2 doi: 10.1186/1471-2105-9-S1-S18 – ident: e_1_3_2_38_2 doi: 10.1038/nsmb.1421 – ident: e_1_3_2_42_2 doi: 10.1074/jbc.M112.392878 – ident: e_1_3_2_3_2 doi: 10.1006/viro.1999.9820 – ident: e_1_3_2_28_2 doi: 10.1128/JVI.01698-07 – ident: e_1_3_2_18_2 doi: 10.1186/1743-422X-10-243 – ident: e_1_3_2_16_2 doi: 10.1128/JVI.01694-10 – ident: e_1_3_2_27_2 doi: 10.1128/JVI.00980-13 – ident: e_1_3_2_7_2 doi: 10.1016/S0140-6736(08)60493-6 – ident: e_1_3_2_32_2 doi: 10.1371/journal.pone.0009025 – volume: 35 start-page: 307 year: 2009 ident: e_1_3_2_47_2 article-title: A barrier function made up of the receptor preference of the virus and the paucity of receptors in human airways against avian influenza virus infection publication-title: Kawasaki Med J – ident: e_1_3_2_23_2 doi: 10.1128/JVI.01373-09 – ident: e_1_3_2_35_2 doi: 10.1099/vir.0.80755-0 – ident: e_1_3_2_46_2 doi: 10.1126/science.1124513 – ident: e_1_3_2_13_2 doi: 10.1038/nsmb1212 – ident: e_1_3_2_36_2 doi: 10.1074/jbc.M300130200 – ident: e_1_3_2_21_2 doi: 10.1038/ncomms1804 – ident: e_1_3_2_45_2 doi: 10.1128/JVI.02677-05 – ident: e_1_3_2_15_2 doi: 10.1128/JVI.02642-09 – reference: 16543414 - Science. 2006 Apr 21;312(5772):404-10 – reference: 18032512 - J Virol. 2008 Feb;82(3):1146-54 – reference: 20181719 - J Virol. 2010 May;84(9):4395-406 – reference: 25289523 - Nat Commun. 2014;5:5021 – reference: 18199865 - N Engl J Med. 2008 Jan 17;358(3):261-73 – reference: 20962098 - J Virol. 2011 Jan;85(1):357-65 – reference: 10430945 - Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50 – reference: 25409142 - Nature. 2014 Dec 18;516(7531):355-60 – reference: 15668219 - N Engl J Med. 2005 Jan 27;352(4):333-40 – reference: 18030326 - PLoS One. 2007;2(11):e1190 – reference: 22090127 - J Virol. 2012 Feb;86(3):1750-7 – reference: 23436652 - J Biol Chem. 2013 Apr 19;288(16):11013-23 – reference: 23555271 - PLoS Pathog. 2013 Mar;9(3):e1003279 – reference: 16140781 - J Virol. 2005 Sep;79(18):12058-64 – reference: 21738783 - PLoS One. 2011;6(6):e21740 – reference: 18454157 - Nat Struct Mol Biol. 2008 May;15(5):500-6 – reference: 20140252 - PLoS One. 2010;5(2):e9025 – reference: 7695269 - Antimicrob Agents Chemother. 1994 Dec;38(12):2827-37 – reference: 10526235 - Genes Cells. 1999 Aug;4(8):475-85 – reference: 15831934 - J Gen Virol. 2005 May;86(Pt 5):1239-49 – reference: 19194458 - Nature. 2009 Apr 16;458(7240):909-13 – reference: 23886034 - Virol J. 2013;10:243 – reference: 17310249 - Nat Struct Mol Biol. 2007 Mar;14(3):229-33 – reference: 17922570 - PLoS Pathog. 2007 Oct 5;3(10):1374-9 – reference: 22090209 - J Gen Virol. 2012 Mar;93(Pt 3):531-40 – reference: 9430591 - Science. 1998 Jan 16;279(5349):393-6 – reference: 7975212 - Virology. 1994 Nov 15;205(1):17-23 – reference: 16007072 - Nature. 2005 Jul 14;436(7048):191-2 – reference: 23616660 - J Virol. 2013 Jul;87(13):7200-9 – reference: 19793828 - J Virol. 2009 Dec;83(23):12325-35 – reference: 20700447 - PLoS Pathog. 2010;6(8):e1001034 – reference: 23926340 - J Virol. 2013 Oct;87(20):11063-75 – reference: 6868370 - Virology. 1983 Jun;127(2):361-73 – reference: 16554799 - Nature. 2006 Mar 23;440(7083):435-6 – reference: 12646557 - J Biol Chem. 2003 May 30;278(22):20381-8 – reference: 18315849 - BMC Bioinformatics. 2008;9 Suppl 1:S18 – reference: 19119420 - PLoS Pathog. 2009 Jan;5(1):e1000252 – reference: 18400288 - Lancet. 2008 Apr 26;371(9622):1427-34 – reference: 10484749 - Virology. 1999 Aug 15;261(1):15-9 – reference: 19194459 - Nature. 2009 Apr 16;458(7240):914-8 – reference: 21816827 - J Biol Chem. 2011 Oct 7;286(40):34504-13 – reference: 16192482 - N Engl J Med. 2005 Sep 29;353(13):1374-85 – reference: 16840327 - J Virol. 2006 Aug;80(15):7469-80 – reference: 20016035 - J Gen Virol. 2010 May;91(Pt 5):1284-9 – reference: 22549831 - Nat Commun. 2012;3:802 |
SSID | ssj0014464 |
Score | 2.312139 |
Snippet | Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60%... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 3947 |
SubjectTerms | Adaptation, Biological Cell Line Epithelial Cells - virology Genetic Diversity and Evolution Humans Influenza A Virus, H5N1 Subtype - genetics Influenza A Virus, H5N1 Subtype - physiology Influenza virus Mutant Proteins - genetics Mutant Proteins - metabolism Mutation, Missense Recombination, Genetic Reverse Genetics Viral Proteins - genetics Viral Proteins - metabolism Virus Replication |
Title | Identification of PB2 Mutations Responsible for the Efficient Replication of H5N1 Influenza Viruses in Human Lung Epithelial Cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25609813 https://www.proquest.com/docview/1662635508 https://www.proquest.com/docview/1676352183 https://pubmed.ncbi.nlm.nih.gov/PMC4403392 |
Volume | 89 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgCIkXNO7lJiPBU5URJ3FiPwLaNKZShGhReYocx94ydenUy6TtkV_O8SVpyjY0eImqEzdN-321_Z2cC0JvdRkVPCYyoCwVQSJoGhS81IGMQpHGOqUyNMnJX4bp_jg5mNDJ2pljs0uWxY68uDKv5H9QBRvgarJk_wHZ9qJggNeALxwBYTjeCGOXZau9282Gs32M-ierpY9vmzcBsFPVhhMqWzPCRADMVfvs2rrz6ZCY2CzTs-RC9M-q-Wpho7V8H78pTAt9dWpyOKbGzW5c_otr9rYmea7rrv8pTsRx5eD0_bobc2l3r9-Pqvq8tQ-cu1xU_W-tqXLBAao-PF7VXV8FoZ0QFze9muqlZo_mVp8rbH5Odm2FPPeyzgQbc1eg8_LMH5lshoMfn3fCOI5AGSfrFa55qj_8mu-NB4N8tDsZ3UZ3IlAWcePg8Q-eQB3bQITmpppciYi97157cxdzSZr8GWHb2bKMttF9jwf-4IjzAN1S9UN013UfPX-Efm3SB880Bvrglj64Qx8M9MGAPG7pgzv0MW819MEtfbCnD1iwpQ829MFr-mBLn8dovLc7-rQf-JYcgUxYvAxUGpWgaQllIVehpqacYBamMhOcMMF4qrOoSEqimExBaVNZxFToghNaJgksjvETtFXPavUMYSULwmWcZUxr0MBKEJAGIRFMSq7KRPdQv_mJc-nr1Zu2KdPc6taI5QBIbgEB_dpD79rRp65OyzXj3jRo5TCRmu8qajVbLXKS2sJMIFj-NsbUbzSqooeeOoTbTzPagTMCZ7IN7NsBppD75pm6OrIF3ZMEbo9Hz29wby_QvfUf6yXaWs5X6hVsi5fFa0vk34hTvX0 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+PB2+mutations+responsible+for+the+efficient+replication+of+H5N1+influenza+viruses+in+human+lung+epithelial+cells&rft.jtitle=Journal+of+virology&rft.au=Yamaji%2C+Reina&rft.au=Yamada%2C+Shinya&rft.au=Le%2C+Mai+Q&rft.au=Li%2C+Chengjun&rft.date=2015-04-01&rft.issn=1098-5514&rft.eissn=1098-5514&rft.volume=89&rft.issue=7&rft.spage=3947&rft_id=info:doi/10.1128%2FJVI.03328-14&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |